European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ. Alfred Witjes, Antoine G. van der Heijden, Anja Lorch et al.|European Urology|2023Cited by 618
Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline EndorsementMatthew I. Milowsky, Cheryl T. Lee, R. Bryan Rumble et al.|Journal of Clinical Oncology|2016Cited by 235
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G. van der Heijden, Michael Rink, Harman Max Bruins et al.|European Urology|2025Cited by 159
Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIUC): A multicenter phase 2 trial.Minas P. Economides, Scot A. Niglio, Matthew I. Milowsky et al.|Journal of Clinical Oncology|2023Cited by 8